PRISM BioLab Co. LTD Statistics
Want to see JP:206A full AI Analyst Report?
PRISM BioLab Co. LTD (206A) Stock Statistics & Valuation Metrics
Total Valuation
PRISM BioLab Co. LTD has a market cap or net worth of JPY 3.96B. The enterprise value is JPY 2.99B.
- Market Cap
- JPY 3.96B
- Enterprise Value
- JPY 2.99B
Share Statistics
PRISM BioLab Co. LTD has 37,039,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 37,039,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PRISM BioLab Co. LTD’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -28.52%.
- Return on Equity (ROE)
- -0.31
- Return on Assets (ROA)
- -0.27
- Return on Invested Capital (ROIC)
- -28.52%
- Return on Capital Employed (ROCE)
- -0.29
- Revenue Per Employee
- 19.35M
- Profits Per Employee
- -23.82M
- Employee Count
- 35
- Asset Turnover
- 0.22
- Inventory Turnover
- 0.00
Income Statement
In the last 12 months, PRISM BioLab Co. LTD had revenue of 677.33M and earned -833.70M in profits. Earnings per share was -22.82.
- Revenue
- 677.33M
- Gross Profit
- 269.76M
- Operating Income
- -774.45M
- Pretax Income
- -831.28M
- Net Income
- -833.70M
- EBITDA
- -831.28M
- Earnings Per Share (EPS)
- -22.82
Stock Price Statistics
- Beta
- 1.21
- 52-Week Price Change
- -23.81%
- 50-Day Moving Average
- 147.26
- 200-Day Moving Average
- 164.62
- Relative Strength Index (RSI)
- 34.43
- Average Volume (3m)
- 100.55K
Important Dates
PRISM BioLab Co. LTD upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- ―
Financial Position
PRISM BioLab Co. LTD as a current ratio of 8.21, with Debt / Equity ratio of 0.00%
- Current Ratio
- 8.21
- Quick Ratio
- 8.21
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 3.51
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, PRISM BioLab Co. LTD has paid 2.42M in taxes.
- Income Tax
- 2.42M
- Effective Tax Rate
- -0.00
Analyst Forecast
The average price target for PRISM BioLab Co. LTD is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 84.23%
- EPS Growth Forecast
- 33.14%
Scores
- Smart Score
- ―
- AI Score
- 41
